Learning > The art of GORD treatment

GORD: progress in clinical understanding. Eamonn M M Quigley MD Professor of medicine and Human Physiology and Head of the Medical School National University of Ireland, Cork

Progress through the module by clicking on the navigation bar below

 

To summarize this section, it seems reasonable to suggest that there may indeed be three unique groups of patients with gastroesophageal reflux disease, those with nonerosive reflux disease, erosive esophagitis, and Barrett's esophagus. A nonerosive disease is nonprogressive and may feature atypical manifestations. Erosive disease may progress to stricture and may be complicated by ulceration with or without gastrointestinal bleeding. Barrett's esophagus, of course, is of particular concern because of its association with adenocarcinoma of the esophagus.

 

Need help using Gastro-Pro? All contents copyright© GastroHOPES Ltd unless otherwise noted. GastroHOPES Ltd and Gastro-Pro do not sell products or services. The contents of this website are intended for access by healthcare professionals only. This website is not intended for patient education. Minors and those of a sensitive nature might find some sounds and images on this site distressing. Visitors are invited to read our privacy policy and full legal notice. Last updated 30.10.03